InflaRx IFRX
NASDAQ IFRX
$1.56 +0.03 (+1.96%)
At close: Oct 23, 2026 · 4:00 PM EDT

InflaRx (IFRX) Cash & Current Investments (2016 - 2026)

Updated

InflaRx's Cash & Current Investments came in at $184.25 million for Q2 2026, down 100.0% from $39.61 trillion a year earlier but up 295.4% from the prior quarter.

Analysis

InflaRx (IFRX) Cash & Current Investments (2016 - 2026) Analysis & Trends

At the end of FY2025, InflaRx's Cash & Current Investments was $52.49 million, down 100.0% from FY2024.

  • Cash & Current Investments has declined in each of the last three years, with a five-year compound annual growth rate of -94.0% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $36.83 trillion in FY2024 (-55.8%), $83.39 trillion in FY2023 (-2.7%), $85.7 trillion in FY2022 (+4.6%) and $81.91 trillion in FY2021 (+24.5%).
  • The five-year range for quarterly Cash & Current Investments is $34.74 million (Q3 2021) to $85.7 trillion (Q4 2022).
  • Year-over-year, Cash & Current Investments has declined for four consecutive quarters, with an average decline of 54.2% over the last seven quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q3 2022 (growth of 171.7%), and the weakest in Q2 2024 (a decline of 100.0%).
  • Business Quant data shows IFRX's Cash & Current Investments at $46.6 million (Q1 2026), $54.08 million (Q4 2025) and $52.19 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 InflaRx 105.31 Mn -228.31 Mn 2.74 Mn 181.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 181.06 Mn
Mar 31, 2026 45.61 Mn
Dec 31, 2025 54.57 Mn
Sep 30, 2025 52.38 Mn
Jun 30, 2025 56.29 Mn
Mar 31, 2025 71.29 Mn
Dec 31, 2024 55.01 Mn
Sep 30, 2024 64.66 Mn
Jun 30, 2024 80.30 Mn
Mar 31, 2024 90.58 Mn
Dec 31, 2023 99.92 Mn
Sep 30, 2023 119.94 Mn
Jun 30, 2023 105.55 Mn
Mar 31, 2023 70.75 Mn
Dec 31, 2022 86.43 Mn
Sep 30, 2022 92.02 Mn
Jun 30, 2022 96.34 Mn
Mar 31, 2022 100.48 Mn
Dec 31, 2021 125.31 Mn
Sep 30, 2021 108.97 Mn
API Access

InflaRx Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IFRX&period=max&api_key=YOUR_API_KEY